Feasibility of mesenchymal stem cell culture expansion for a phase I clinical trial in multiple sclerosis.

Multiple sclerosis journal - experimental, translational and clinical(2018)

引用 11|浏览6
暂无评分
摘要
Culture expansion of mesenchymal stem cells from multiple sclerosis patients as donors is feasible. However, culture time should be minimized for cell products designated for therapeutic administration.
更多
查看译文
关键词
Multiple sclerosis,clinical trial,culture expansion,cytogenetic analysis,mesenchymal stem cell
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要